
Guardian Pharmacy Services Inc GRDN.N, GRDN.K is expected to report resultson May 12 for the period ending March 31 2025
The Atlanta Georgia-based company is expected to report revenue of $321.214 million, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Guardian Pharmacy Services Inc is for earnings of 18 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 8.3% in the last three months.
Wall Street's median 12-month price target for Guardian Pharmacy Services Inc is $25.00, below its last closing price of $25.48.
This summary was machine generated May 9 at 20:47 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)